包装D1
多囊肾病
医学
常染色体显性多囊肾病
多囊性肝病
肾
囊性肾病变
内科学
基因检测
胃肠病学
疾病
囊肿
家族史
肾脏疾病
病理
内分泌学
移植
肝移植
作者
Takuya Fujimaru,Takayasu Mori,Akinari Sekine,Shintaro Mandai,Motoko Chiga,Hiroaki Kikuchi,Fumiaki Ando,Yutaro Mori,Naohiro Nomura,Soichiro Iimori,Seiji Naito,Tomokazu Okado,Tatemitsu Rai,Junichi Hoshino,Yoshifumi Ubara,Shinichi Uchida,Eisei Sohara
摘要
Distinguishing autosomal‐dominant polycystic kidney disease (ADPKD) from other inherited renal cystic diseases in patients with adult polycystic kidney disease and no family history is critical for correct treatment and appropriate genetic counseling. However, for patients with no family history, there are no definitive imaging findings that provide an unequivocal ADPKD diagnosis. We analyzed 53 adult polycystic kidney disease patients with no family history. Comprehensive genetic testing was performed using capture‐based next‐generation sequencing for 69 genes currently known to cause hereditary renal cystic diseases including ADPKD. Through our analysis, 32 patients had PKD1 or PKD2 mutations. Additionally, 3 patients with disease‐causing mutations in NPHP4 , PKHD1 , and OFD1 were diagnosed with an inherited renal cystic disease other than ADPKD. In patients with PKD1 or PKD2 mutations, the prevalence of polycystic liver disease, defined as more than 20 liver cysts, was significantly higher (71.9% vs 33.3%, P = .006), total kidney volume was significantly increased (median, 1580.7 mL vs 791.0 mL , P = .027) and mean arterial pressure was significantly higher (median, 98 mm Hg vs 91 mm Hg, P = .012). The genetic screening approach and clinical features described here are potentially beneficial for optimal management of adult sporadic polycystic kidney disease patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI